Meihua International Medical Technologies Co., Ltd. (MHUAF) Stock Price & Analysis
Meihua International Medical Technologies Co., Ltd. (MHUAF) — price $5.05 (-4.72%), as of the Nov 19, 2026 trading session; market cap $4.32M.
Educational signal · not a buy or sell recommendation · How to read this
Meihua International Medical Technologies Co., Ltd. · MHUAF
Meihua International Medical Technologies Co., Ltd. is a China-based manufacturer of disposable medical devices, serving hospitals, pharmacies, and medical institutions globally. The company offers a range of Class I, II, and III medical devices, including X-ray films, anesthesia kits, and infusion pumps.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $5.05 | |
| Change on the day | -4.72% | |
| 52-week range | $2.05 – $26.00 | |
| Market capitalisation | $4.32M | — |
| Price / earnings (trailing) | 0.36 | |
| Shares traded on the day | 1 |
Price & events
Other perspectives
Council score for Meihua International Medical Technologies Co. (MHUAF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 7, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 30, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 30, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Meihua International Medical Technologies Co. (MHUAF), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Meihua International Medical Technologies Co., Ltd. (MHUAF) is the company analyzed here. It employs 486 people and is led by Lee Leyi. In Q4 FY2025 it reported revenue of $24M and net income of $4M. The market values it at $4.32M.
What do the latest results show for Meihua International Medical Technologies Co. (MHUAF)?
Short answer · as of
The most recent reported quarter, Q4 FY2025, carried revenue of $24M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2025 | $24M | $4M | $5.23 (diluted) |
| Q2 FY2025 | $38M | $3M | $9.86 (diluted) |
| Q4 FY2024 | $52M | $6M | $21.00 (diluted) |
| Q2 FY2024 | $45M | $5M | $15.36 (diluted) |
What are the financial strengths and risks for Meihua International Medical Technologies Co. (MHUAF)?
Short answer · as of
The distress and quality screens read Altman Z 2.11 · Piotroski F 4. Trailing ratios: ROE 3.8% · ROA 3.3% · current ratio 8.42 · earnings yield 162.5% · free-cash-flow yield 13.2%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held MHUAF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported MHUAF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Meihua International Medical Technologies Co. Stock: Key Questions Answered
These answers are editorial: 1 of these 8 answers is drawn from the MHUAF research dossier (written Mar 17, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is MHUAF a good stock to buy?
Stock Expert AI does not rate MHUAF buy, sell or hold. Meihua International Medical Technologies Co., Ltd. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the MHUAF stock price today?
The last price recorded for Meihua International Medical Technologies Co., Ltd. (MHUAF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for MHUAF?
Meihua International Medical Technologies Co., Ltd. faces several risks, including regulatory changes in the medical device industry, which could affect product approvals and compliance. Fluctuations in currency exchange rates could impact export revenues.
What are the key factors to evaluate for MHUAF?
Evaluate MHUAF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. The company exports its products to multiple continents, indicating a global presence. Not financial advice.
How frequently does MHUAF data refresh on this page?
MHUAF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven MHUAF's recent stock price performance?
Meihua International Medical Technologies Co., Ltd. (MHUAF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio covering multiple classes of medical devices. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MHUAF overvalued or undervalued right now?
The trailing P/E of Meihua International Medical Technologies Co., Ltd. (MHUAF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research MHUAF before investing?
Before investing in Meihua International Medical Technologies Co., Ltd. (MHUAF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 14 figures on this page — 8 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com